Todd Feaster, PsyD is a neuropsychologist with more than 20 years of experience in Alzheimer’s disease (AD) and other CNS indications. He joined Acumen as a Clinical Research Scientist in April 2022. Prior to joining Acumen, Dr Feaster was the Director of Clinical Science at Signant Health where he was responsible for leading studies and providing clinical and scientific oversight for their AD clinical trial portfolio. Todd also has expertise in the design and creation of electronic Clinical Outcome Assessments (eCOA). Many of the eCOA scales he developed are currently being used in multinational AD trials. Prior to joining Signant Health, Dr Feaster was a neuropsychologist and clinical researcher at the MidAmerica Neuroscience Institute. There he worked across many neurological indications with special interest and expertise in the areas of Alzheimer’s disease, Multiple Sclerosis, and Sleep. Todd earned his Doctor of Psychology (PsyD) degree from the Forest Institute of Professional Psychology.